STEP Trial Results

Overview

STEP-1 through STEP-4 trials established semaglutide's weight-management efficacy. Pivotal STEP-1 (NEJM 2021, PMID 33567185): 14.9% mean weight loss at 2.4 mg / 68 weeks.

PubMed citations

• PMID 33567185

Related clinical pages

• STEP trial results
• SELECT trial results
• FLOW trial results
• Mechanism of action
• Dosing & pharmacology
• Contraindications
• Side effects